Interstitial Chemotherapy and Polymer Drug Delivery

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Malignant gliomas are among the most aggressive, rapidly progressive, and lethal tumors. Their historically poor prognosis has improved with research-driven advancements using intraoperative imaging and targeted therapeutics. However, recurrence remains a difficult challenge, underscoring both the limitations of surgery, and the need for a creative, multimodal approach in targeting these locally invasive neoplasms. Unique physiological barriers of the central nervous system that normally protect the brain from foreign substances present complex challenges that limit the delivery and efficacy of conventionally delivered chemotherapeutics. To bypass these barriers and limit harmful systemic toxicities, local polymer-based delivery strategies have been developed and continue to be improved. In this chapter, we examine the details of malignant glioma in order to review the history and rationale that supports different polymer-based systems of interstitial chemotherapeutic delivery. Finally, we explore the future role these drug delivery systems will play as they are used in conjunction with developing modalities such as immunotherapy and personalized medicine to advance the care and prognosis of patients with brain malignancies.

Original languageEnglish (US)
Title of host publicationHandbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
Subtitle of host publicationSecond Edition
PublisherElsevier Inc.
Pages155-165
Number of pages11
ISBN (Print)9780128121009
DOIs
StatePublished - Apr 24 2018

Fingerprint

Polymers
Drug Therapy
Glioma
Pharmaceutical Preparations
Neoplasms
Precision Medicine
Brain
Drug Delivery Systems
Immunotherapy
Patient Care
Central Nervous System
History
Recurrence
Research
Therapeutics

Keywords

  • Blood-brain barrier
  • Drug delivery
  • Glioma
  • Polymer

ASJC Scopus subject areas

  • Medicine(all)
  • Neuroscience(all)

Cite this

Gorelick, N., Jackson, E., Tyler, B. M., & Brem, H. (2018). Interstitial Chemotherapy and Polymer Drug Delivery. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition (pp. 155-165). Elsevier Inc.. https://doi.org/10.1016/B978-0-12-812100-9.00011-5

Interstitial Chemotherapy and Polymer Drug Delivery. / Gorelick, Noah; Jackson, Eric; Tyler, Betty Mae; Brem, Henry.

Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., 2018. p. 155-165.

Research output: Chapter in Book/Report/Conference proceedingChapter

Gorelick, N, Jackson, E, Tyler, BM & Brem, H 2018, Interstitial Chemotherapy and Polymer Drug Delivery. in Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., pp. 155-165. https://doi.org/10.1016/B978-0-12-812100-9.00011-5
Gorelick N, Jackson E, Tyler BM, Brem H. Interstitial Chemotherapy and Polymer Drug Delivery. In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc. 2018. p. 155-165 https://doi.org/10.1016/B978-0-12-812100-9.00011-5
Gorelick, Noah ; Jackson, Eric ; Tyler, Betty Mae ; Brem, Henry. / Interstitial Chemotherapy and Polymer Drug Delivery. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition. Elsevier Inc., 2018. pp. 155-165
@inbook{c1795670a34e45c0b8abf7999e492a76,
title = "Interstitial Chemotherapy and Polymer Drug Delivery",
abstract = "Malignant gliomas are among the most aggressive, rapidly progressive, and lethal tumors. Their historically poor prognosis has improved with research-driven advancements using intraoperative imaging and targeted therapeutics. However, recurrence remains a difficult challenge, underscoring both the limitations of surgery, and the need for a creative, multimodal approach in targeting these locally invasive neoplasms. Unique physiological barriers of the central nervous system that normally protect the brain from foreign substances present complex challenges that limit the delivery and efficacy of conventionally delivered chemotherapeutics. To bypass these barriers and limit harmful systemic toxicities, local polymer-based delivery strategies have been developed and continue to be improved. In this chapter, we examine the details of malignant glioma in order to review the history and rationale that supports different polymer-based systems of interstitial chemotherapeutic delivery. Finally, we explore the future role these drug delivery systems will play as they are used in conjunction with developing modalities such as immunotherapy and personalized medicine to advance the care and prognosis of patients with brain malignancies.",
keywords = "Blood-brain barrier, Drug delivery, Glioma, Polymer",
author = "Noah Gorelick and Eric Jackson and Tyler, {Betty Mae} and Henry Brem",
year = "2018",
month = "4",
day = "24",
doi = "10.1016/B978-0-12-812100-9.00011-5",
language = "English (US)",
isbn = "9780128121009",
pages = "155--165",
booktitle = "Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Interstitial Chemotherapy and Polymer Drug Delivery

AU - Gorelick, Noah

AU - Jackson, Eric

AU - Tyler, Betty Mae

AU - Brem, Henry

PY - 2018/4/24

Y1 - 2018/4/24

N2 - Malignant gliomas are among the most aggressive, rapidly progressive, and lethal tumors. Their historically poor prognosis has improved with research-driven advancements using intraoperative imaging and targeted therapeutics. However, recurrence remains a difficult challenge, underscoring both the limitations of surgery, and the need for a creative, multimodal approach in targeting these locally invasive neoplasms. Unique physiological barriers of the central nervous system that normally protect the brain from foreign substances present complex challenges that limit the delivery and efficacy of conventionally delivered chemotherapeutics. To bypass these barriers and limit harmful systemic toxicities, local polymer-based delivery strategies have been developed and continue to be improved. In this chapter, we examine the details of malignant glioma in order to review the history and rationale that supports different polymer-based systems of interstitial chemotherapeutic delivery. Finally, we explore the future role these drug delivery systems will play as they are used in conjunction with developing modalities such as immunotherapy and personalized medicine to advance the care and prognosis of patients with brain malignancies.

AB - Malignant gliomas are among the most aggressive, rapidly progressive, and lethal tumors. Their historically poor prognosis has improved with research-driven advancements using intraoperative imaging and targeted therapeutics. However, recurrence remains a difficult challenge, underscoring both the limitations of surgery, and the need for a creative, multimodal approach in targeting these locally invasive neoplasms. Unique physiological barriers of the central nervous system that normally protect the brain from foreign substances present complex challenges that limit the delivery and efficacy of conventionally delivered chemotherapeutics. To bypass these barriers and limit harmful systemic toxicities, local polymer-based delivery strategies have been developed and continue to be improved. In this chapter, we examine the details of malignant glioma in order to review the history and rationale that supports different polymer-based systems of interstitial chemotherapeutic delivery. Finally, we explore the future role these drug delivery systems will play as they are used in conjunction with developing modalities such as immunotherapy and personalized medicine to advance the care and prognosis of patients with brain malignancies.

KW - Blood-brain barrier

KW - Drug delivery

KW - Glioma

KW - Polymer

UR - http://www.scopus.com/inward/record.url?scp=85054646518&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054646518&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-812100-9.00011-5

DO - 10.1016/B978-0-12-812100-9.00011-5

M3 - Chapter

AN - SCOPUS:85054646518

SN - 9780128121009

SP - 155

EP - 165

BT - Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy

PB - Elsevier Inc.

ER -